Results 61 to 70 of about 304,343 (339)

Paroxysmal Dyskinesias Secondary to HHV‐6A Encephalitis: The First Case Report and Literature Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paroxysmal dyskinesias encompasses a spectrum of conditions marked by intermittent involuntary movements, with paroxysmal kinesigenic dyskinesias being the most common phenotype. Central nervous system infection is a rare cause of paroxysmal dyskinesias.
Zhuoran Wang, Haiting Li, Xiaoping Du, Qiong Wang, Yating Zhang, Huifang Wang   +5 more
wiley   +1 more source

Measles in 2019 - Going Backward.

New England Journal of Medicine, 2019
Measles in 2019 — Going Backward Recent increases in measles cases in the United States mirror patterns in other countries that had previously eliminated the virus.
Catharine I. Paules, Hilary D. Marston, A. Fauci   +2 more
semanticscholar   +1 more source

Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Multiple sclerosis (MS) patients often experience a higher incidence of clinical conditions before diagnosis, suggesting a prodromal phase. However, their predictive value and temporal trajectories remain underexplored. We investigated these aspects using the large UK Biobank's population‐based cohort, which provided clinical ...
Andrea Nova, Teresa Fazia, Giovanni Di Caprio, Davide Gentilini, Luisa Bernardinelli, Roberto Bergamaschi   +5 more
wiley   +1 more source

Polyanhydride‐Based Microparticles for Programmable Pulsatile Release of Diphtheria Toxoid (DT) for Single‐Injection Self‐Boosting Vaccines

Advanced Materials, EarlyView.
This study presents a polyanhydride‐based delivery platform for single‐injection, self‐boosting vaccines. The system enables programmable, pulsatile release of diphtheria toxoid with high antigen recovery and is guided by machine learning for tunability. In vivo results show immune responses comparable to multi‐dose regimens, highlighting its potential
Linzixuan Zhang, Ruiqing Xiao, Wenhao Gao, Johnny Garcia, Xinyan Pan, John L. Daristotle, Timothy Forster, Jooli Han, Mehr Chaddah, Dhruv Varshney, Nandita Menon, Kevin J. McHugh, Benjamin J. Pedretti, Jing Ying Yeo, Xin Yang, Sydney MacDonald, Robert Langer, Ana Jaklenec   +17 more
wiley   +1 more source

Genetic characterization of measles virus circulating in Iran, 2021–2023

BMC Infectious Diseases
Background Measles, an ongoing public health concern, demands continuous molecular surveillance and virus characterization for elimination. Despite Iran achieving measles elimination status in 2019 through robust molecular testing and vaccination, the ...
Alireza Esmaeiloghli Amiryli, Simin Abbasi, Faezeh Tarpoor, Azadeh Shadab, Azam Saboori, Nazanin-Zahra Shafiei Jandaghi, Vahid Salimi, Talat Mokhtari-Azad   +7 more
doaj   +1 more source

Towards Measles elimination [PDF]

, 2003
In many European countries measles is still a cause of great public health concern. Outbreaks of the disease are still occurring because the degree of vaccination coverage required to interrupt transmission has not yet been achieved.
Muscat, Mark, Sciberras, Maria
core  

Predictors of measles vaccination coverage among children 6-59 months of age in the Democratic Republic of the Congo. [PDF]

, 2018
BackgroundMeasles is a significant contributor to child mortality in the Democratic Republic of the Congo (DRC), despite routine immunization programs and supplementary immunization activities (SIA).
Alfonso, Vivian H, Ashbaugh, Hayley R, Cherry, James D, Doshi, Reena H, Gadoth, Adva, Gerber, Sue K, Hoff, Nicole A, Mukadi, Patrick, Muyembe-Tamfum, Jean Jacques, Okitolonda-Wemakoy, Emile, Rimoin, Anne W   +10 more
core   +1 more source

Progress Toward Regional Measles Elimination — Worldwide, 2000–2018

MMWR. Morbidity and mortality weekly report, 2019
In 2010, the World Health Assembly (WHA) set the following three milestones for measles control to be achieved by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) among children aged 1 year to ≥90% at the ...
Minal K. Patel, Laure Dumolard, Yoann Nedelec, S. Sodha, Claudia Steulet, M. Gacic-Dobo, K. Kretsinger, J. Mcfarland, P. Rota, J. Goodson   +9 more
semanticscholar   +1 more source

Implantable Microarray Patch: Engineering at the Nano and Macro Scale for Sustained Therapeutic Release via Synthetic Biodegradable Polymers

Advanced Materials Technologies, Volume 10, Issue 6, March 18, 2025.
This review focuses on the application of synthetic biodegradable microarray patches (MAPs) in sustained drug delivery. Compared to conventional MAPs which release drugs into the skin in an immediate manner, these implantable MAPs release drugs into skin microcirculation gradually as the biodegradable polymers degrade, thus offering sustained release ...
Li Zhao, Akmal Hidayat Bin Sabri, Mary B. McGuckin, Linlin Li, Zihao Wang, Eneko Larrañeta, Ryan F. Donnelly   +6 more
wiley   +1 more source

The measles epidemic trend over the past 30 years in a central district in Shanghai, China.

PLoS ONE, 2017
BackgroundMeasles vaccination over the past 50 years has greatly reduced the incidence of measles. However, measles among migrants and the resulting changes in epidemiological characteristics have brought new challenges to the elimination of measles.
Jie Gao, Bing Shen, JianJing Xiong, Yihan Lu, Qingwu Jiang   +4 more
doaj   +1 more source